» Articles » PMID: 15922855

Growth of LNCaP Cells in Monoculture and Coculture with Osteoblasts and Response to TNOX Inhibitors

Overview
Journal Cancer Lett
Specialty Oncology
Date 2005 Jun 1
PMID 15922855
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

An in vitro coculture model of prostate cancer cells (LNCaP) with human osteoblasts (hFOB) was utilized to define the efficacy of the tNOX inhibitors EGCg, capsaicin, Capsibiol-T and phenoxodiol against bone metastasis of prostate cancer alone and in combination with Taxol and cisplatin. In general, the LNCaP cells were more resistant to treatment with EGCg, capsaicin, phenoxodiol and Taxol when grown in coculture than when grown in monoculture. Only with Capsibiol-T (50 microM) was growth of LNCaP cells in coculture inhibited comparable with monoculture. Pretreatment with Capsibiol-T followed by the treatment with Taxol had an additive effect on reduction of viability of LNCaP cells in monoculture. In contrast, an antagonistic effect of cisplatin was observed following capsaicin pretreatment.

Citing Articles

The Natural Chemotherapeutic Capsaicin Activates AMPK through LKB1 Kinase and TRPV1 Receptors in Prostate Cancer Cells.

Sanchez B, Bort A, Mora-Rodriguez J, Diaz-Laviada I Pharmaceutics. 2022; 14(2).

PMID: 35214061 PMC: 8880011. DOI: 10.3390/pharmaceutics14020329.


Anti-cancer analogues ME-143 and ME-344 exert toxicity by directly inhibiting mitochondrial NADH: ubiquinone oxidoreductase (Complex I).

Lim S, Carey K, McKenzie M Am J Cancer Res. 2015; 5(2):689-701.

PMID: 25973307 PMC: 4396027.


Effect of sodium chloride on efficiency of cisplatinum dissolved in dimethyl sulfoxide: an in vitro study.

Doun S, Khor S, Qujeq D, Ebrahimi Shahmabadi H, Alavi S, Movahedi F Indian J Clin Biochem. 2014; 29(2):242-5.

PMID: 24757310 PMC: 3990798. DOI: 10.1007/s12291-013-0361-9.


Cytotoxic effects of the novel isoflavone, phenoxodiol, on prostate cancer cell lines.

Mahoney S, Arfuso F, Rogers P, Hisheh S, Brown D, Millward M J Biosci. 2012; 37(1):73-84.

PMID: 22357205 DOI: 10.1007/s12038-011-9170-6.


Pharmacokinetics of phenoxodiol, a novel isoflavone, following intravenous administration to patients with advanced cancer.

Howes J, de Souza P, West L, Huang L, Howes L BMC Clin Pharmacol. 2011; 11:1.

PMID: 21291562 PMC: 3045896. DOI: 10.1186/1472-6904-11-1.